|
|
CONTENTS
|
|
|
DEFINITION
OF BIOCHEMICAL RECURRENCE
(BCR)
NATURAL
HISTORY OF BIOCHEMICAL RECURRENCE
ASSESSMENT
OF METASTASES
TREATMENT
OF BIOCHEMICAL
RECURRENCE
AFTER RADICAL PROSTATECTOMY
OVERVIEW
SALVAGE RADIOTHERAPY (SRT)
ANDROGEN
DEPRIVATION THERAPY
(ADT)
TREATMENT
OPTIONS OTHER THAN RADIATION AND ANDROGEN DEPRIVATION
OBSERVATION
TREATMENT
OF BIOCHEMICAL
RECURRENCE
AFTER RADIATION THERAPY
■
SALVAGE
RADICAL PROSTATECTOMY (SRP)
SALVAGE
CRYOABLATION OF THE PROSTATE
SALVAGE
BRACHYTHERAPY FOR RADIOTHERAPY FAILURE
SALVAGE
HIGH-INTENSITY FOCUSED ULTRASOUND (HIFU)
OBSERVATION
GUIDELINES
|
Also
in this page:
GENERAL
OVERVIEW
ADT
AFTER PRIMARY TREATMENT
CHEMOTHERAPY
PLUS HORMONE THERAPY
|
|
|
GENERAL
OVERVIEW
|
|
.
|
Artibani W, Porcaro AB, De Marco V, Cerruto MA, Siracusano S.
Management of Biochemical Recurrence after Primary
Curative Treatment for Prostate Cancer: A Review.
Urol
Int. 2017 Nov 21. doi: 10.1159/000481438. [Epub ahead of print]
Source
| Full
text |
Similar
articles
|
|
|
.
|
Bruce
JY, Lang JM, McNeel DG, Liu G.
Current
controversies in the management of biochemical failure in prostate
cancer.
Clin
Adv Hematol Oncol. 2012 Nov;10(11):716-22.
Source
|
Full
text |
Similar
articles
|
|
|
.
|
Paller
CJ, Antonarakis ES.
Management
of biochemically recurrent prostate cancer after local therapy:
evolving standards of care and new directions.
Clin
Adv Hematol Oncol. 2013 Jan;11(1):14-23.
Source
| Full
text |
Similar
articles
|
|
|
.
|
Punnen S, Cooperberg MR, D'Amico AV, Karakiewicz PI, Moul JW,
Scher HI, Schlomm T, Freedland SJ.
Management of
biochemical recurrence after primary treatment of prostate cancer:
a systematic review of the literature.
Eur Urol. 2013
Dec;64(6):905-15. doi: 10.1016/j.eururo.2013.05.025. Epub 2013 May
16.
Source
| Full
text |
Similar
articles
|
|
|
.
|
Spratt DE, McHugh DJ, Morris MJ, Morgans AK.
Management
of Biochemically Recurrent Prostate Cancer: Ensuring the Right
Treatment of the Right Patient at the Right Time.
Am Soc
Clin Oncol Educ Book. 2018 May 23;(38):355-362. doi:
10.1200/EDBK_200319.
Source
| Book
|
Similar
articles
|
|
|
ADT
AFTER PRIMARY TREATMENT
|
|
|
|
OPTIMAL
TIMING OF ADT INITIATION
|
Dale W,
Hemmerich J, Bylow K, Mohile S, Mullaney M, Stadler WM.
Patient
anxiety about prostate cancer independently predicts early
initiation of androgen deprivation therapy for biochemical cancer
recurrence in older men: a prospective cohort study.
J
Clin Oncol. 2009 Apr 1;27(10):1557-63. doi:
10.1200/JCO.2008.18.5850. Epub 2009 Mar 2.
Source
| Full
text |
Similar
articles
|
|
|
.
|
Schröder
F, Bangma C, Angulo JC, Alcaraz A, Colombel M, McNicholas T,
Tammela TL, Nandy I, Castro R.
Dutasteride
Treatment Over 2 Years Delays Prostate-specific Antigen
Progression in Patients with Biochemical Failure After Radical
Therapy for Prostate Cancer: Results from the Randomised,
Placebo-controlled Avodart After Radical Therapy for Prostate
Cancer Study (ARTS).
Eur
Urol. 2013 May;63(5):779-87. doi: 10.1016/j.eururo.2012.11.006.
Epub 2012 Nov 12.
Source
|
Full
text |
Similar
articles
|
|
|
.
|
Taneja SS.
Re:
dutasteride treatment over 2 years delays prostate-specific
antigen progression in patients with biochemical failure after
radical therapy for prostate cancer: results from the randomised,
placebo-controlled avodart after radical therapy for prostate
cancer study (ARTS).
J Urol. 2013
May;189(5):1716. doi: 10.1016/j.juro.2013.01.077. Epub 2013 Jan
30.
Comment
relating
to:
Schröder
F et
al., Eur Urol. 2013 May;63(5):779-87. doi:
10.1016/j.eururo.2012.11.006. Epub 2012 Nov 12.
Source
| Full
text |
Similar
articles
|
|
|
CHEMOTHERAPY
PLUS HORMONE THERAPY
|
|
.
|
Nakabayashi
M, Xie W, Buckle G, Bubley G, Ernstoff MS, Walsh W, Morganstern
DE, Kantoff PW, Taplin ME.
Long-term
follow-up of a phase II trial of chemotherapy plus hormone therapy
for biochemical relapse after definitive local therapy for
prostate cancer.
Urology.
2013 Mar;81(3):611-6. doi: 10.1016/j.urology.2012.12.025.
Source
| Full
text |
Similar
articles
|
|
|
|
|
|
|
